JP2024536858A5 - - Google Patents

Info

Publication number
JP2024536858A5
JP2024536858A5 JP2024518772A JP2024518772A JP2024536858A5 JP 2024536858 A5 JP2024536858 A5 JP 2024536858A5 JP 2024518772 A JP2024518772 A JP 2024518772A JP 2024518772 A JP2024518772 A JP 2024518772A JP 2024536858 A5 JP2024536858 A5 JP 2024536858A5
Authority
JP
Japan
Prior art keywords
phenyl
amino
methyl
pyrrolo
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536858A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/121076 external-priority patent/WO2023046117A1/en
Publication of JP2024536858A publication Critical patent/JP2024536858A/ja
Publication of JP2024536858A5 publication Critical patent/JP2024536858A5/ja
Pending legal-status Critical Current

Links

JP2024518772A 2021-09-23 2022-09-23 Fgfr阻害剤及びその使用方法 Pending JP2024536858A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2021119861 2021-09-23
CNPCT/CN2021/119861 2021-09-23
CN2022096894 2022-06-02
CNPCT/CN2022/096894 2022-06-02
PCT/CN2022/121076 WO2023046117A1 (en) 2021-09-23 2022-09-23 Fgfr inhibitors and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024536858A JP2024536858A (ja) 2024-10-08
JP2024536858A5 true JP2024536858A5 (enExample) 2025-06-25

Family

ID=85720119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518772A Pending JP2024536858A (ja) 2021-09-23 2022-09-23 Fgfr阻害剤及びその使用方法

Country Status (8)

Country Link
US (1) US20240383905A1 (enExample)
EP (1) EP4405358A4 (enExample)
JP (1) JP2024536858A (enExample)
KR (1) KR20240075952A (enExample)
CN (1) CN118043327A (enExample)
AU (1) AU2022350571A1 (enExample)
CA (1) CA3231948A1 (enExample)
WO (1) WO2023046117A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117402161A (zh) * 2022-07-06 2024-01-16 上海科恩泰生物医药科技有限公司 一种具有fgfr抑制作用的亚砜亚胺类化合物、包含其的药物组合物及其用途
CN115232147B (zh) * 2022-08-09 2023-10-13 南方科技大学 一种作为HIF-2α激动剂的杂环衍生物
WO2024109799A1 (zh) * 2022-11-22 2024-05-30 西藏海思科制药有限公司 一种嘧啶衍生物及其在医药上的应用
WO2024208315A1 (zh) * 2023-04-07 2024-10-10 中国医药研究开发中心有限公司 芳香杂环类化合物及其制备方法和医药用途
EP4707277A1 (en) * 2023-05-04 2026-03-11 Daewoong Pharmaceutical Co., Ltd. Novel heterocyclic amine derivatives and pharmaceutical composition comprising same
WO2024245193A1 (zh) * 2023-05-26 2024-12-05 上海艾力斯医药科技股份有限公司 杂芳环类化合物、其药物组合物及其应用
KR20260115897A (ko) * 2023-11-17 2026-07-27 상하이 치루 파마슈티컬 리서치 앤 디벨롭먼트 센터 리미티드 질소 함유 헤테로아릴 유도체, 이의 제조 방법 및 의약학적 응용
WO2025149021A1 (zh) * 2024-01-10 2025-07-17 海思科医药集团股份有限公司 一种吡啶并吡咯衍生物及其在医药上的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9808281A (pt) * 1997-03-19 2000-05-16 Basf Ag Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto
GB0031080D0 (en) * 2000-12-20 2001-01-31 Novartis Ag Organic compounds
US7232823B2 (en) * 2003-06-09 2007-06-19 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
WO2005061504A1 (en) * 2003-12-16 2005-07-07 Pfizer Products Inc. Bicyclic pyridazinone cannabinoid receptor ligands and uses thereof
DE102008052943A1 (de) * 2008-10-23 2010-04-29 Merck Patent Gmbh Azaindolderivate
CN105837576B (zh) * 2015-01-14 2019-03-26 湖北生物医药产业技术研究院有限公司 Btk抑制剂
CN107417687A (zh) * 2016-05-24 2017-12-01 中国科学院上海药物研究所 五元杂环并[3,4‑d]哒嗪酮类化合物、其制备方法、药物组合物及其应用
CN108997380A (zh) * 2018-07-26 2018-12-14 长春海谱润斯科技有限公司 一种嘌呤化合物及其有机电致发光器件
ES3065954T3 (en) * 2019-05-13 2026-05-08 Relay Therapeutics Inc Fgfr inhibitors and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2022184886A5 (enExample)
CN118974055A (zh) 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
JP7860103B2 (ja) 複素環式スピロ化合物及びその使用方法
RU2473549C2 (ru) Пиримидиновые соединения, композиции и способы применения
RU2431635C2 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
JP2024532735A (ja) 複素環式化合物及び使用方法
JP2018529731A5 (enExample)
JP2024532733A (ja) 複素環式化合物及び使用方法
JP2016537384A5 (enExample)
JP2016538316A5 (enExample)
JP2013523884A5 (enExample)
JP2010510319A5 (enExample)
JP2017524007A5 (enExample)
RU2019115115A (ru) Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7
RU2007134899A (ru) ПРОИЗВОДНЫЕ АЦЕТИЛЕНИЛ-ПИРАЗОЛО-ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGLuR2
TW201619159A (zh) 吡咯并[2,3-d]嘧啶衍生物
RU2009140469A (ru) Производные пирролопиримидин-7-она и их применение в качестве фармацевтических средств
JP2012501312A5 (enExample)
JP2021518379A5 (enExample)
JP2017518326A5 (enExample)
JP2014511355A5 (enExample)
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения
JP2006512366A5 (enExample)
JP2024539620A5 (enExample)